Everolimus Zentiva 2.5 mg
Everolimus Zentiva 2.5 mg is a medicine authorised by Swissmedic under authorisation number 68000. The authorisation holder is Helvepharm AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 20 May 2021 and the authorisation is valid without a time limit. ATC code L01EG02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68000 |
|---|---|
| Name | Everolimus Zentiva 2.5 mg |
| Full name | Everolimus Zentiva 2.5 mg, Tabletten |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EG02 |
| First authorisation | 20 May 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Everolimus Zentiva 2.5 mg, Tabletten | A | 20 May 2021 |
| 2 | Everolimus Zentiva 5 mg, Tabletten | A | 20 May 2021 |
| 3 | Everolimus Zentiva 10 mg, Tabletten | A | 20 May 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | L01EG02 | 07.16.4. | A |
| 2 | 30 | Tablette(n) | L01EG02 | 07.16.4. | A |
| 3 | 30 | Tablette(n) | L01EG02 | 07.16.4. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Everolimus Zentiva 2.5 mg authorised in Switzerland?
Yes. Everolimus Zentiva 2.5 mg is authorised by Swissmedic under authorisation number 68000, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Everolimus Zentiva 2.5 mg have?
Everolimus Zentiva 2.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Everolimus Zentiva 2.5 mg?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.